Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kevyn E. Merten
Observed names:
Kevyn E Merten,
Kevyn Merten
Observed institution:
University of Louisville
OpenAlex ID:
A5047026067
Bone selective effect of an estradiol conjugate with a novel tetracycline-derived bone-targeting agent
2008
·
Jason R. Neale
, Natali B. Richter
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
66
Calcineurin Activation Is Not Necessary for Doxorubicin-Induced Hypertrophy in H9c2 Embryonic Rat Cardiac Cells: Involvement of the Phosphoinositide 3-Kinase-Akt Pathway
2006
·
Kevyn E. Merten
, Youchun Jiang
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
50
Modulation of Cytochrome c Oxidase-Va Is Possibly Involved in Metallothionein Protection from Doxorubicin Cardiotoxicity
2005
·
Kevyn E. Merten
, Wenke Feng
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
44
Zinc inhibits doxorubicin-activated calcineurin signal transduction pathway in H9c2 embryonic rat cardiac cells.
2007
·
Kevyn E Merten
, Youchun Jiang
, et al.
·
PubMed
·
18
Novel Bone-Targeting Agent for Enhanced Delivery of Vancomycin to Bone
2015
·
Zaineb A. F. Albayati
, Manjula Sunkara
, et al.
·
Antimicrobial Agents and Chemotherapy
·
16
PDF
Treatment of Methicillin-resistant Staphylococcus aureus experimental Osteomyelitis with bone-targeted Vancomycin
2013
·
Melissa J Karau
, Suzannah M Schmidt-Malan
, et al.
·
SpringerPlus
·
16
PDF
ChemInform Abstract: Bone Selective Effect of an Estradiol Conjugate with a Novel Tetracycline‐Derived Bone‐Targeting Agent.
2009
·
Jason R. Neale
, Natali B. Richter
, et al.
·
ChemInform
·
1
Show more works
View as search
Works count:
7
Citation count:
211
H-index:
6
I10-index:
6
Year
Topic
Type
